Rennova Health, Inc.
RNVA
RNVA was delisted on the 24th of October, 2017.
9 hedge funds and large institutions have $135K invested in Rennova Health, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
43% less capital invested
Capital invested by funds: $236K → $135K (-$101K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$76.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$21K |
| 3 |
VF
Virtu Financial
New York
|
+$15.2K |
| 4 |
Bank of New York Mellon
New York
|
+$8.66K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$5.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$287 |
RNVA Hedge Fund Activity: Q3 2017 in Review
9 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q3 2017, worth a combined $135K — down 43% from $236K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RNVA positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $76.4K. The largest seller was Deutsche Bank, exiting entirely with an estimated $287 sold.
- 9 institutional investors held Rennova Health, Inc. (RNVA) as of Q3 2017, up from 8 in Q2 2017.
- Funds reported $135K of Rennova Health, Inc. stock for Q3 2017, down 43% quarter-over-quarter.
- 3 funds opened new Rennova Health, Inc. positions in Q3 2017 and 1 closed out, a net change of +2 holders.
- The largest Rennova Health, Inc. buyer in Q3 2017 was Sabby Management, an estimated $76.4K added.
- The largest Rennova Health, Inc. seller in Q3 2017 was Deutsche Bank, an estimated $287 sold.
Based on aggregated 13F filings for Q3 2017.